Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multi-omics signature of brain amyloid deposition in asymptomatic individuals at-risk for Alzheimer's disease: The INSIGHT-preAD study.
Xicota L, Ichou F, Lejeune FX, Colsch B, Tenenhaus A, Leroy I, Fontaine G, Lhomme M, Bertin H, Habert MO, Epelbaum S, Dubois B, Mochel F, Potier MC; INSIGHT study group. Xicota L, et al. Among authors: lejeune fx. EBioMedicine. 2019 Sep;47:518-528. doi: 10.1016/j.ebiom.2019.08.051. Epub 2019 Sep 3. EBioMedicine. 2019. PMID: 31492558 Free PMC article.
Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer's disease.
Penner G, Lecocq S, Chopin A, Vedoya X, Lista S, Vergallo A, Cavedo E, Lejeune FX, Dubois B, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI). Penner G, et al. Among authors: lejeune fx. PLoS One. 2021 Jan 4;16(1):e0243902. doi: 10.1371/journal.pone.0243902. eCollection 2021. PLoS One. 2021. PMID: 33395442 Free PMC article.
Association of plasma Aβ40/Aβ42 ratio and brain Aβ accumulation: testing a whole-brain PLS-VIP approach in individuals at risk of Alzheimer's disease.
Lemercier P, Vergallo A, Lista S, Zetterberg H, Blennow K, Potier MC, Habert MO, Lejeune FX, Dubois B, Teipel S, Hampel H; INSIGHT-preAD study group and the Alzheimer Precision Medicine Initiative (APMI). Lemercier P, et al. Among authors: lejeune fx. Neurobiol Aging. 2021 Nov;107:57-69. doi: 10.1016/j.neurobiolaging.2021.07.005. Epub 2021 Jul 14. Neurobiol Aging. 2021. PMID: 34388400 Free article.
Blood-based diagnostics of Alzheimer's disease.
Penner G, Lecocq S, Chopin A, Vedoya X, Lista S, Vergallo A, Lejeune FX, Hampel H. Penner G, et al. Among authors: lejeune fx. Expert Rev Mol Diagn. 2019 Jul;19(7):613-621. doi: 10.1080/14737159.2019.1626719. Epub 2019 Jun 8. Expert Rev Mol Diagn. 2019. PMID: 31177871 Review.
Multimodal assessment improves neuroprognosis performance in clinically unresponsive critical-care patients with brain injury.
Rohaut B, Calligaris C, Hermann B, Perez P, Faugeras F, Raimondo F, King JR, Engemann D, Marois C, Le Guennec L, Di Meglio L, Sangaré A, Munoz Musat E, Valente M, Ben Salah A, Demertzi A, Belloli L, Manasova D, Jodaitis L, Habert MO, Lambrecq V, Pyatigorskaya N, Galanaud D, Puybasset L, Weiss N, Demeret S, Lejeune FX, Sitt JD, Naccache L. Rohaut B, et al. Among authors: lejeune fx. Nat Med. 2024 Aug;30(8):2349-2355. doi: 10.1038/s41591-024-03019-1. Epub 2024 May 30. Nat Med. 2024. PMID: 38816609 Free PMC article.
50 results